Arch Therapeutics launched a private placement fundraising effort, offering 11.4 million shares of common stock in hopes of raising $2.9 million.
Funding Roundup
Preceptis Medical closes $4.4M round
Preceptis Medical said it closed a funding round worth $4.4 million.
Plymouth, Minn.-based Preceptis Medical makes surgical tools for a children’s ear tube procedure called pediatric tympanostomy surgery.
The Preceptis ear tube introducer, which is in a clinical trial ahead of an application for 510(k) clearance from the FDA, is designed to eliminate the need for general anesthesia during tympanostomies.
Mela Sciences plans reboot with $12M financing
Titan Medical prices Canadian offering
Titan Medical (CVE:TMD) priced a public stock offering in Canada at C$1.40 per share, saying it will allow the size of the offering to be determined by "the context of the market."
Vital Images, Toshiba land close to $200M in DoD deals
Vital Images and Toshiba Medical Systems’ (TYO:6502) American division secured a combined $198 million in separate supply deals with the U.S. Dept. of Defense.
Diabetes: Intuity Medical raises $5M
Intuity Medical met it $5.5 million goal in a recent funding round, SEC filings show.
Sunnyvale, Calif.-based Intuity, a spin-off of research group Sarnoff Corporation, is working to simplify diabetes management. The company’s flagship product is the POGO blood glucose monitoring system, which integrates test strips and a lancing device into one system. The POGO technology currently has only investigational device classification, according to the company’s website.
RenovoRx raises over $1M Series B round
RenovoRx closed its Series B financing round, bringing in about $1.2 million for the catheter maker.
The San Jose, Calif.-based medical device company is working on catheter technology that directly delivers fluids to the peripheral vascular system. The financing round was led by angel funding group Golden Seeds, alongside the Angels’ Forum, Astia Angels and Amidzad Partners.
Inogen plans for $75M IPO
Inogen narrowed the price range for the initial public offering it registered late last year, saying it expects to price the IPO at $16 to $18 per share.
That would make the 4.4-million-share offering worth $70.6 million to $79.4 million; if the shares sell at the midpoint, Inogen would raise about $75.0 million.
PowerVision raises $4M so far in $30M round
PowerVision is trying to fundraise $30 million, having so far brought in $4 million, according to a regulatory filing.
X-Bolt Orthopaedics lands nearly $3M in funding
X-Bolt Orthopaedics raised $2.5 million (€1.8m) to put its hip fracture repair device on the market.
Dublin-based X-Bolt develops and manufactures devices for hip fractures. The company’s marquee product is an expanding bolt placed where the hip fractures, designed to help decrease the need for repeat surgeries.
Medtronic, J&J put more skin in PowerVision’s intraocular lens
California-based PowerVision touted another round of fundraising backed by some of the biggest names in medtech.